Page last updated: 2024-12-07

s-benzyl-n-acetyl-l-cysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

S-benzyl-N-acetyl-L-cysteine (SNAC) is a synthetic derivative of the amino acid L-cysteine. It is a potent antioxidant and free radical scavenger that has been shown to protect cells from oxidative damage. SNAC is also a prodrug of N-acetyl-L-cysteine (NAC), which is a well-known mucolytic agent used to treat respiratory conditions such as chronic obstructive pulmonary disease (COPD). SNAC has been studied for its potential therapeutic applications in a variety of diseases, including cancer, neurodegenerative disorders, and cardiovascular disease. SNAC is synthesized by reacting L-cysteine with benzyl bromide in the presence of a base. The resulting product is then acetylated to yield SNAC. SNAC is a promising therapeutic agent with a wide range of potential applications. However, further research is needed to fully understand its efficacy and safety in humans.'
```

S-benzyl-N-acetyl-L-cysteine: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-acetyl-S-benzyl-L-cysteine : The S-benzyl derivative of N-acetyl-L-cysteine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID107816
CHEBI ID165854
SCHEMBL ID7282451
MeSH IDM0093570

Synonyms (28)

Synonym
sbnac
19542-77-9
benzylmercapturic acid
CHEBI:165854
(2r)-2-acetamido-3-benzylsulanylpropanoic acid
n-acetyl-s-benzyl-l-cysteine
(2r)-2-acetamido-3-benzylsulfanylpropanoic acid
unii-x3h719rfpt
l-cysteine, n-acetyl-s-(phenylmethyl)-
s-benzylmercapturic acid
s-benzyl-n-acetyl-l-cysteine
x3h719rfpt ,
2r)-2-acetamido-3-(phenylmethylsulfanyl)propanoic acid
SCHEMBL7282451
(r)-2-acetamido-3-(benzylthio)propanoic acid
AKOS024306968
AC-29503
n -acetyl-s-(benzyl)-l-cysteine
F31244
DS-9210
DTXSID90894753
Q4890819
mfcd00038237
n-acetyl-s-benzyl-l-cysteine (ac-l-cys(bzl)-oh)
(2r)-2-acetamido-3-benzylsulfanyl-propanoic acid
CS-0154009
(2r)-3-(benzylsulfanyl)-2-acetamidopropanoic acid
n-acetyl-s-(phenylmethyl)-l-cysteine; n-acetyl-3-(benzylthio)-alanine; benzylmercapturic acid; acetyl benzyl cysteine; s-benzylmercapturic acid;

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Male Fischer 344 rats were dosed by gavage with [methylene-14C]benzyl acetate (500 mg/kg) alone or together with pyrazole (200 mg/kg), pentachlorophenol (10 mg/kg) or both pentachlorophenol (10 mg/kg) and pyrazole (200 mg/kg), given in each case ip."( Studies on benzyl acetate. II. Use of specific metabolic inhibitors to define the pathway leading to the formation of benzylmercapturic acid in the rat.
Caldwell, J; Chidgey, MA; Kennedy, JF, 1986
)
0.27
" First, the efficacy of the acivicin treatment was established from a dose-response investigation in which urinary gamma-GT was measured daily in rats exposed to 1750 ppm toluene, 6 h per day for five days."( Toluene-induced hearing loss in acivicin-treated rats.
Campo, P; Cosnier, F; Cossec, B; Ferrari, L; Grossman, S; Waniusiow, D,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
rat metaboliteAny mammalian metabolite produced during a metabolic reaction in rat (Rattus norvegicus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
S-substituted N-acetyl-L-cysteine
organic sulfideCompounds having the structure RSR (R =/= H). Such compounds were once called thioethers.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (17.24)18.7374
1990's5 (17.24)18.2507
2000's10 (34.48)29.6817
2010's5 (17.24)24.3611
2020's4 (13.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.10 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]